PLX: HOLD Alapkezelo Zrt. owns 5.2%
- 4,157,791 shares
- 5.2% of common stock
- Filed on 2026-10-15
Alapkezelo Zrt. Hold, filed by
PLX
Protalix BioTherapeutics, Inc. SEC filings
Every EDGAR filing for Protalix BioTherapeutics, Inc. (PLX), newest first, with AI summaries and stories.
- Ticker
- PLX
- CIK
- 1006281
- Latest filing
- 4d
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13GProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE4Protalix BioTherapeutics, Inc.PLXLIVE Aharon Schwartz, insider filing for PLX
Aharon Schwartz, reporting
ROUTINE4Protalix BioTherapeutics, Inc.PLXLIVE 8 insider filings
Eliot Forster, insider filing for PLX
Show all 8
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
- 4Insider filing for PLX
Eliot Forster, reporting
NOTABLE10-QProtalix BioTherapeutics, Inc.PLXLIVE ROUTINES-8Protalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINESCHEDULE 13GProtalix BioTherapeutics, Inc.PLXLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE NOTABLE10-QProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINEARSProtalix BioTherapeutics, Inc.PLXLIVE ROUTINEDEF 14AProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE3/AProtalix BioTherapeutics, Inc.PLXLIVE Gilad Mamlok, new insider at PLX (amended)
Gilad Mamlok, reporting
ROUTINESCHEDULE 13G/AProtalix BioTherapeutics, Inc.PLXLIVE Ownership stake disclosure by MAK Capital Fund LP (amended)
MAK Capital Fund LP, filed by
NOTABLE10-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINESCHEDULE 13GProtalix BioTherapeutics, Inc.PLXLIVE Ownership stake disclosure by MAK Capital Fund LP
MAK Capital Fund LP, filed by
ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE4Protalix BioTherapeutics, Inc.PLXLIVE Dror Bashan, insider filing for PLX
Dror Bashan, reporting
ROUTINE4Protalix BioTherapeutics, Inc.PLXLIVE Protalix BioTherapeutics, Inc. - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Amos Bar-Shalev, reporting
NOTABLE10-QProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.PLXLIVE ROUTINE8-KProtalix BioTherapeutics, Inc.LIVE